Aethlon Medical, Inc. (AEMD) financial statements (2021 and earlier)

Company profile

Business Address 9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO, CA 92123
State of Incorp. NV
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments121047221
Cash and cash equivalents121047221
Receivables00 0 00
Other undisclosed current assets0000000
Total current assets:121047221
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0000000
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Deposits noncurrent assets00000  
Other noncurrent assets     0 
Other undisclosed noncurrent assets0     0
Total noncurrent assets:0000000
TOTAL ASSETS:131047231
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0000000
Accounts payable0000000
Interest and dividends payable      0
Deferred revenue 0
Debt  1    
Due to related parties0000000
Other liabilities1010000
Other undisclosed current liabilities00    (0)
Total current liabilities:1120111
Noncurrent Liabilities
Long-term debt and lease obligation 0 1110
Long-term debt, excluding current maturities   1110
Operating lease, liability 0
Other undisclosed noncurrent liabilities (0)     
Total noncurrent liabilities: 0 1110
Total liabilities:1121111
Stockholders' equity
Stockholders' equity attributable to parent12926121
Common stock0000000
Additional paid in capital129121108106948882
Accumulated deficit(118)(112)(106)(99)(94)(87)(82)
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)0
Total stockholders' equity:11926121
TOTAL LIABILITIES AND EQUITY:131047231

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenue, net0011
Other income      0
Gross profit:1100011
Operating expenses(8)(7)(6)(5)(6)(5)(5)
Other operating expense, net
(Other Expenses)
      (3)
Other undisclosed operating income      3
Operating loss:(7)(6)(6)(5)(6)(4)(4)
Nonoperating expense(0)(0)     
Interest and debt expense0(0)(0)(0)(0)(1)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)      
Loss before gain (loss) on sale of properties:(7)(6)(6)(5)(6)(5)(4)
Other undisclosed net income (loss)00 (1)(1) (3)
Net loss:(7)(6)(6)(6)(7)(5)(7)
Net income (loss) attributable to noncontrolling interest(0)000000
Net loss attributable to parent:(7)(6)(6)(6)(7)(5)(7)
Other undisclosed net loss available to common stockholders, basic(0)      
Net loss available to common stockholders, diluted:(7)(6)(6)(6)(7)(5)(7)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net loss:(7)(6)(6)(6)(7)(5)(7)
Comprehensive loss:(7)(6)(6)(6)(7)(5)(7)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)000000
Comprehensive loss, net of tax, attributable to parent:(7)(6)(6)(6)(7)(5)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: